Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency
Fotocitizen / Pixabay

Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency
Patricia Brown Joins CureDuchenne as Senior Director of Engagement to Advance Mission of Finding Duchenne Muscular Dystrophy Cure
rawpixel / Pixabay

Patricia Brown Joins CureDuchenne as Senior Director of Engagement to Advance Mission of Finding Duchenne Muscular Dystrophy Cure

For over 20 years, CureDuchenne, a Patient Worthy partner and global nonprofit, has moved steadfastly forward with a mission to find, and fund, a cure for individuals with Duchenne muscular…

Continue Reading Patricia Brown Joins CureDuchenne as Senior Director of Engagement to Advance Mission of Finding Duchenne Muscular Dystrophy Cure
Sarepta is Pushing to Expand Duchenne Muscular Dystrophy Drug Label Despite Missed Endpoints
source: shutterstock.com

Sarepta is Pushing to Expand Duchenne Muscular Dystrophy Drug Label Despite Missed Endpoints

Sarepta Therapeutics’ treatment Elevidys (delandistrogene moxeparvovec-rokl) received conditional approval from the FDA in June 2023. The designation implies that if the drug is used in accordance with its label, it…

Continue Reading Sarepta is Pushing to Expand Duchenne Muscular Dystrophy Drug Label Despite Missed Endpoints
ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer
Photo by Wengang Zhai on Unsplash

ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer

The American Society of Clinical Oncology (ASCO) held its ASCO Gastrointestinal Cancers Symposium from January 18-20, 2024. During the Symposium, doctors, researchers, scientists, and other stakeholders discussed innovative science and…

Continue Reading ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer

Knowledge is Power: CureDuchenne Cares Educational Events Aim to Equip Families and Caregivers in the Becker and Duchenne Muscular Dystrophy Communities

CureDuchenne, a global leader in research and patient care for Duchenne muscular dystrophy (DMD), has been working to find and fund a cure for DMD for more than two decades.…

Continue Reading Knowledge is Power: CureDuchenne Cares Educational Events Aim to Equip Families and Caregivers in the Becker and Duchenne Muscular Dystrophy Communities
Boy with MHC Class II Deficiency Successfully Treated with Bone Marrow Transplant
source: shutterstock.com

Boy with MHC Class II Deficiency Successfully Treated with Bone Marrow Transplant

For the first six months of his life, Miller Gamberi seemed to be a happy, healthy boy. But his health suddenly shifted; Miller stopped wanting to eat and drink. His…

Continue Reading Boy with MHC Class II Deficiency Successfully Treated with Bone Marrow Transplant
Study Suggests that Perinatal Depression Risk is Significantly Higher in Women with Autoimmune Diseases
source: pixabay.com

Study Suggests that Perinatal Depression Risk is Significantly Higher in Women with Autoimmune Diseases

Type 1 diabetes (T1D), rheumatoid arthritis, lupus, and ulcerative colitis are all examples of autoimmune diseases. An autoimmune disease is a condition that occurs when the immune system mistakenly attacks…

Continue Reading Study Suggests that Perinatal Depression Risk is Significantly Higher in Women with Autoimmune Diseases
Rare Community Profiles: How Matrix Can Be Leveraged to Co-Create and Co-Deliver Care in the Rare Disease Space
Fotocitizen / Pixabay

Rare Community Profiles: How Matrix Can Be Leveraged to Co-Create and Co-Deliver Care in the Rare Disease Space

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: How Matrix Can Be Leveraged to Co-Create and Co-Deliver Care in the Rare Disease Space
Preventing Breast Cancer: Scientists Identify ‘Key’ to Potential Treatment and Prevention
source: shutterstock.com

Preventing Breast Cancer: Scientists Identify ‘Key’ to Potential Treatment and Prevention

The immune system is constantly on the alert for cells that have sustained DNA damage. When a cell divides its DNA molecules are, to varying degrees, usually damaged. Yet researchers…

Continue Reading Preventing Breast Cancer: Scientists Identify ‘Key’ to Potential Treatment and Prevention